172 related articles for article (PubMed ID: 32275456)
41. Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease.
de Mello CG; Branquinho RT; Oliveira MT; Milagre MM; Saúde-Guimarães DA; Mosqueira VC; Lana Md
Antimicrob Agents Chemother; 2016 Sep; 60(9):5215-22. PubMed ID: 27324760
[TBL] [Abstract][Full Text] [Related]
42. Preparation and
Zhen L; Wei Q; Wang Q; Zhang H; Adu-Frimpong M; Kesse Firempong C; Xu X; Yu J
Pharm Dev Technol; 2020 Jan; 25(1):1-8. PubMed ID: 30557068
[TBL] [Abstract][Full Text] [Related]
43. The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction.
Laeis P; Püchler K; Kirch W
J Hypertens Suppl; 2001 Jun; 19(1):S21-32. PubMed ID: 11451211
[TBL] [Abstract][Full Text] [Related]
44. Experimentally designed lyophilized dry emulsion tablets for enhancing the antihyperlipidemic activity of atorvastatin calcium: Preparation, in-vitro evaluation and in-vivo assessment.
Salama AH; Basha M; El Awdan S
Eur J Pharm Sci; 2018 Jan; 112():52-62. PubMed ID: 29117504
[TBL] [Abstract][Full Text] [Related]
45. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
[TBL] [Abstract][Full Text] [Related]
46. Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement.
Thakkar HP; Patel BV; Thakkar SP
J Pharm Bioallied Sci; 2011 Jul; 3(3):426-34. PubMed ID: 21966165
[TBL] [Abstract][Full Text] [Related]
47. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
48. Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.
Clementino AR; Pellegrini G; Banella S; Colombo G; Cantù L; Sonvico F; Del Favero E
Mol Pharm; 2021 Aug; 18(8):3132-3146. PubMed ID: 34259534
[TBL] [Abstract][Full Text] [Related]
49. Increase in Dissolution Rate of Zotepine via Nanomilling Process - Impact of Dried Nanocrystalline Suspensions on Bioavailability.
Parmar K; Oza K
AAPS PharmSciTech; 2021 Dec; 23(1):20. PubMed ID: 34907489
[TBL] [Abstract][Full Text] [Related]
50. In vitro evaluation and in vivo performance of lyophilized gliclazide.
Mansour HF; Aly UF
Drug Dev Ind Pharm; 2015 Apr; 41(4):650-7. PubMed ID: 24568609
[TBL] [Abstract][Full Text] [Related]
51. Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug.
Nassar T; Rohald A; Naraykin N; Barasch D; Amsalem O; Prabhu P; Kotler M; Benita S
J Drug Target; 2019; 27(5-6):590-600. PubMed ID: 30470150
[TBL] [Abstract][Full Text] [Related]
52. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
Limayem Blouza I; Charcosset C; Sfar S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
[TBL] [Abstract][Full Text] [Related]
53. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine.
Park MJ; Balakrishnan P; Yang SG
Int J Pharm; 2013 Jan; 441(1-2):757-64. PubMed ID: 23089581
[TBL] [Abstract][Full Text] [Related]
54. Bioavailability assessment of vitamin A self-nanoemulsified drug delivery systems in rats: a comparative study.
Taha E; Ghorab D; Zaghloul AA
Med Princ Pract; 2007; 16(5):355-9. PubMed ID: 17709923
[TBL] [Abstract][Full Text] [Related]
55. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.
Albash R; Abdelbary AA; Refai H; El-Nabarawi MA
Int J Nanomedicine; 2019; 14():1953-1968. PubMed ID: 30936696
[TBL] [Abstract][Full Text] [Related]
56. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Singh G; Pai RS
Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
[TBL] [Abstract][Full Text] [Related]
57. Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation.
Rui TQ; Zhang L; Qiao HZ; Huang P; Qian S; Li JS; Chen ZP; Fu TM; Di LQ; Cai B
J Pharm Sci; 2016 Jan; 105(1):242-9. PubMed ID: 26852855
[TBL] [Abstract][Full Text] [Related]
58. Visualisation of real-time oral biodistribution of fluorescent labeled self-microemulsifying drug delivery system of olmesartan medoxomil using optical imaging method.
Komesli Y; Yildirim Y; Karasulu E
Drug Metab Pharmacokinet; 2021 Feb; 36():100365. PubMed ID: 33191089
[TBL] [Abstract][Full Text] [Related]
59. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
60. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
